BRD9 and myelodysplastic syndrome: Since exon 15 inclusion in BRD9 has been reported to lead to nonsense-mediated decay and lower transcript levels in UVM and MDS, we sought to investigate BRD9 gene expression levels in additional cancer types that harbor SF3B1 mutations [18].